Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer among women across the world. From our perspective, improved treatment options and earlier detection could have a positive impact on decreasing mortality, as this could offer more options for successful intervention and therapies when the disease is still in its early stages.
Ron Blankstein, M.D., director of cardiac computed tomography, Brigham and Women's Hospital, and associate professor of ...
Quynh Truong, M.D., MPH, associate professor of radiology and medicine at Weill Cornell and director of cardiac CT ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Rural America does not show up in any atlas but, geographically, it accounts for 80 percent of the United States’ land ...
Recent advances in digital radiography (DR) are increasing demand for whole spine imaging before, during and after back ...

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-capable cells a competitive advantage over normal cells in healthy tissue, scientists have discovered. Researchers at the Wellcome Sanger Institute and the University of Cambridge studied the effects of low doses of radiation in the esophagus of mice.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are now ...
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes. Qlarity Imaging will further develop QuantX, the U.S. Food and Drug Administration (FDA)-cleared computer-aided breast cancer diagnosis system.
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School of Medicine has been designated a qualified provider-led entity (qPLE). This allows Johns Hopkins to develop criteria that meet the requirements of the federal Protecting Access to Medicare Act (PAMA) of 2014 when ordering diagnostic imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and nuclear imaging in the emergency department and ambulatory settings.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to Imaging Market Trends ...
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM) for radiation oncology on July 10, 2019. In response, the American Society for Radiation Oncology (ASTRO) issued the following statement from Paul Harari, M.D., FASTRO, chair of the ASTRO Board of Directors.
July 17, 2019 — The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the alliance will be to double five-year survival for patients with lung cancer by 2025.
July 17, 2019 — Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to ...
A lot of computers are being made without disk readers, an indication that this form of media is on the way out. So why ...
July 16, 2019 — Computational pathology company Paige announced the publication of an article in Nature Medicine ...
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to quickly send 3-D DICOM volumetric data to colleagues for one-click review. The updated version provides a U.S. Food and Drug Administration (FDA)-approved 3-D DICOM web viewer with new tools such as measurements, the ability to discuss cases with messaging, viewing of mesh file types such as STL and more.
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting, July 14-18 in San Antonio, Texas.
NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility is part of NorthStar’s staged development and dual processing pathway approach to expanding current capacity and efficiencies in Mo-99 production.